RUTA SAVICKIENE: Open Payments
NPI 1902181407 · JOLIET, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 15 payments from 8 companies in 2025. Trend: 2023 $634 · 2024 $645 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 4 | $89 |
| Amgen Inc. | 3 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Mannkind Corporation | 2 | $41 |
| Astellas Pharma US Inc | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: RECORLEV, TEPEZZA, CAPLYTA, AFREZZA, Veozah, XYOSTED, FARXIGA.
Industry payments across IL — which companies pay providers there.
